Next Article in Journal
RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15, 1565
Previous Article in Journal
Targeted Delivery of 5-Fluorouracil and Sonidegib via Surface-Modified ZIF-8 MOFs for Effective Basal Cell Carcinoma Therapy
Previous Article in Special Issue
Comparison of Bovine- and Porcine-Derived Decellularized Biomaterials: Promising Platforms for Tissue Engineering Applications
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(11), 2595; https://doi.org/10.3390/pharmaceutics15112595
Action Date Notes Link
article xml file uploaded 7 November 2023 07:04 CET Original file -
article xml uploaded. 7 November 2023 07:04 CET Update -
article pdf uploaded. 7 November 2023 07:04 CET Version of Record -
article supplementary file uploaded. 7 November 2023 07:04 CET - https://www.mdpi.com/1999-4923/15/11/2595#supplementary
article html file updated 7 November 2023 07:06 CET Original file -
article xml file uploaded 7 November 2023 07:29 CET Update -
article xml uploaded. 7 November 2023 07:29 CET Update https://www.mdpi.com/1999-4923/15/11/2595/xml
article pdf uploaded. 7 November 2023 07:29 CET Updated version of record https://www.mdpi.com/1999-4923/15/11/2595/pdf
article html file updated 7 November 2023 07:30 CET Update https://www.mdpi.com/1999-4923/15/11/2595/html
Back to TopTop